Albert David Limited (BOM:524075)
649.95
+9.65 (1.51%)
At close: Mar 25, 2026
Albert David Market Cap
Albert David has a market cap or net worth of 3.47 billion as of March 27, 2026. Its market cap has decreased by -26.15% in one year.
Market Cap
3.47B
Enterprise Value
1.04B
Revenue
3.23B
Ranking
n/a
PE Ratio
36.09
Stock Price
649.95
Market Cap Chart
Since October 30, 2001, Albert David's market cap has increased from 80.47M to 3.47B, an increase of 4,210.28%. That is a compound annual growth rate of 16.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 3.71B | -12.17% |
| Dec 31, 2025 | 4.22B | -44.14% |
| Dec 31, 2024 | 7.56B | 35.71% |
| Dec 29, 2023 | 5.57B | 71.95% |
| Dec 30, 2022 | 3.24B | -6.10% |
| Dec 31, 2021 | 3.45B | 36.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kopran | 5.57B |
| Sudarshan Pharma Industries | 5.49B |
| Kilitch Drugs (India) | 5.34B |
| Jenburkt Pharmaceuticals | 4.23B |
| Amanta Healthcare | 3.31B |
| ZIM Laboratories | 3.30B |
| Medicamen Biotech | 3.06B |
| Medico Remedies | 2.89B |